<DOC>
	<DOC>NCT01177514</DOC>
	<brief_summary>The primary aims of this study are to determine if treatment with Gabapentin taken systemically (oral tablets) in patients who have photorefractive keratectomy (PRK) surgical treatments reduces post surgical neuropathic pain and discomfort. The investigators main Hypothesis is that gabapentin given prior to and after refractive surgery prevents central sensitization and local allodynia.</brief_summary>
	<brief_title>The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1. Subjects must be at least 18 years of age 2. Subjects must not have any corneal disease or degeneration 3. Subjects must be candidates for LASIK or PRK refractive surgery 1. History of topical ocular medications within 4 weeks prior to enrollment 2. History of conjunctivitis or ocular inflammation within 4 weeks prior to enrollment 3. History of a previous refractive surgery 4. History of previous diagnosis of corneal disease, degeneration, or glaucoma 5. History of autoimmune disease 6. History of oral antihistamines currently or within 1 week of study enrollment 7. History of systemic antiinflammatory or pain medication currently or within 4 weeks of study enrollment 8. Use of oral diuretics or betablocker currently or within 1 week of study enrollment 9. Current diagnosis of dry eye 10. Patients whose Best corrected vision is less than 20/20 11. Patients whose target post operative refraction is not plano 12. Pregnant and lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Refractive surgery</keyword>
	<keyword>PRK</keyword>
	<keyword>PAIN</keyword>
	<keyword>Gabapentin</keyword>
</DOC>